Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-12.15%
↑ 88% vs avg
Percentile
P36
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-103.01%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -12.15% |
| Q3 2025 | 17.35% |
| Q2 2025 | 4.21% |
| Q1 2025 | 2.60% |
| Q4 2024 | -9.12% |
| Q3 2024 | 15.16% |
| Q2 2024 | 4.97% |
| Q1 2024 | -17.02% |
| Q4 2023 | -18.42% |
| Q3 2023 | 13.37% |
| Q2 2023 | -8.18% |
| Q1 2023 | -20.69% |
| Q4 2022 | -8.49% |
| Q3 2022 | 29.30% |
| Q2 2022 | -9.68% |
| Q1 2022 | -17.26% |
| Q4 2021 | 25.80% |
| Q3 2021 | 0.34% |
| Q2 2021 | -127.51% |
| Q1 2021 | -32.28% |
| Q4 2020 | -40.23% |
| Q3 2020 | -2.87% |
| Q2 2020 | -25.03% |
| Q1 2020 | -2845.21% |
| Q4 2019 | -70.52% |
| Q3 2019 | 13.54% |
| Q2 2019 | 50.70% |
| Q1 2019 | 99.95% |
| Q4 2018 | 0.00% |